Update your browser

Your browser (Internet Explorer) is out of date.

Update your browser for more security, comfort and the best experience on this site.

AGY Therapeutics

AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system.

270 East Grand Avenue South, San Francisco, CA 94080, United States

Profile Navigation
This is a community generated profile. If you would like to claim it, please contact us.

About

Our Company

AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs.
AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of the disease process. This is paving the way for novel CNS therapeutics and future growth for AGY.

Markets

areas of proficiency

Company Type

Choose Company Type

Cancel

Company Size

11 - 30

Choose Company Size

Cancel

Contact Info

get in touch

  • Location:

    Other: 270 East Grand Avenue South, San Francisco, CA 94080, United States